Cost-effectiveness and lung cancer clinical trials
Open Access
- 25 August 2003
- Vol. 98 (7) , 1491-1496
- https://doi.org/10.1002/cncr.11659
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2002
- Clinical Trials: Are They a Good Buy?Journal of Clinical Oncology, 2001
- Impact of Clinical Trials on the Cost of Cancer CareMedical Care, 2001
- Variation in Approval by Insurance Companies of Coverage for Autologous Bone Marrow Transplantation for Breast CancerNew England Journal of Medicine, 1994
- Assigning Care Costs Associated With Therapeutic Oncology Research: A Modest ProposalJNCI Journal of the National Cancer Institute, 1992
- A Swift Response to a "Modest" ProposalJNCI Journal of the National Cancer Institute, 1992
- Accrual to cancer clinical trials: Directions from the research literatureSocial Science & Medicine, 1991
- Clinical trials: Access and reimbursementCancer, 1991
- The Crisis in Clinical Cancer ResearchNew England Journal of Medicine, 1988
- Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical AccuracyStatistical Science, 1986